The evolutionary history of lethal metastatic prostate cancer - press releases

The evolutionary history of lethal metastatic prostate cancer - press releases

Daniel Brewer from Norwich Medical School at UEA and The Genome Analysis Centre (TGAC) said: “Prostate cancer becomes lethal once it spreads from the prostate and this study has given us a unique insight into the way this occurs.”
“Contrary to the established simple view of one ‘seed’ of cancer moving from the prostate to other organs, we have firmly established that the process is much more complex and dynamic. Cancer cells are continuously interchanged between all organs where cancer has been established and new sites are established both from the prostate and other organs. This step will help scientist develop new approaches in tackling this wide-spread disease.”

* https://www.uea.ac.uk/about/-/scientists-drill-down-to-genetic-root-of-prostate-tumour-development
* http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2015-04-01-scientists-drill-down-to-genetic-root-of-prostate-tumour-development
* http://www.icr.ac.uk/news-archive/scientists-drill-down-to-genetic-root-of-prostate-tumour-development
https://www.uea.ac.uk/about/-/scientists-drill-down-to-genetic-root-of-prostate-tumour-development

Comments

Post a Comment

Popular posts from this blog

A census of amplified and overexpressed human cancer genes : Nature Reviews Cancer

This paper , that I am an author on, was released on 24th December 2009: "Integrated genome-wide screens of DNA copy number and gene expression in human cancers have accelerated the rate of discovery of amplified and overexpressed genes. However, the biological importance of most of the genes identified in such studies remains unclear. In this Analysis, we propose a weight-of-evidence based classification system for identifying individual genes in amplified regions that are selected for during tumour development. In a census of the published literature we have identified 77 genes for which there is good evidence of involvement in the development of human cancer." I spent a huge amount of time on this one but I am still pretty low on the author pecking order. This is for a super high impact journal, "Nature Reviews Cancer" which has a 2008 ISI Impact Factor of 30.762. Also check out the associated website which I put together just before Christmas. Hopefully, this...
Read more

RT @CancerInNorwich: 📢 Join us on Monday at 1pm for the next talk in our virtual seminar series. We will be hearing from Dr Wafa Al-Jamal from @QUBelfast, who will be talking about "Smart Nanomedicimes for Pancreatic Cancer". All are welcome to join via the MS Teams link: https://t.co/4xCYpjGuBZ https://t.co/EGyD4NAgeP

RT @CancerInNorwich: 📢 Join us on Monday at 1pm for the next talk in our virtual seminar series. We will be hearing from Dr Wafa Al-Jamal from @QUBelfast, who will be talking about "Smart Nanomedicimes for Pancreatic Cancer". All are welcome to join via the MS Teams link: https://t.co/4xCYpjGuBZ https://t.co/EGyD4NAgeP — Daniel Brewer (@danbrewer) May 11, 2023 from Twitter https://twitter.com/danbrewer
Read more

An excellent opportunity to join the cancer genetics team as a diagnostic lab bioinformatician in Norwich. Lots of exciting projects to get involved in. Deadline: 30/05/2023. Happy to chat about this role. https://t.co/SltGsxYF6Y https://t.co/zh08bqZFDb

An excellent opportunity to join the cancer genetics team as a diagnostic lab bioinformatician in Norwich. Lots of exciting projects to get involved in. Deadline: 30/05/2023. Happy to chat about this role. https://t.co/SltGsxYF6Y https://t.co/zh08bqZFDb — Daniel Brewer (@danbrewer) May 19, 2023 from Twitter https://twitter.com/danbrewer
Read more